Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Constantine Logothetis"'
Autor:
Anwaar Saeed, Moh’d Khushman, Hassan Abushukair, Constantine Logothetis, Fawzi Abu Rous, Olivia Aranha
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/d0e88f1fb3314b05a2f7a46ea1bebc4d
Autor:
Praneeth Reddy Sudalagunta, Rafael Canevarolo, Mark Meads, Ariosto Silva, Xiaohong zhao, Christopher Cubitt, Gabriel DeAvila, Raghunandan Reddy Alugubelli, Constantine Logothetis, Alexandre Tungesvik, Qi Zhang, Oliver Hampton, Jamie Teer, Eric Welsh, Sean Yoder, Bijal Shah, Lori Hazlehurst, Robert Gatenby, Dane Van Domelen, Yi Chai, Feng Wang, Andrew DeCastro, Amanda Bloomer, Erin Seigel, Daniel Sullivan, Melissa Alsina, Taiga Nishihori, Jason Brayer, John L. Cleveland, William Dalton, Robert Gillies, Christopher Walker, Yosef Landesman, Rachid Baz, Ariosto Siqueira Silva, Kenneth Shain
We present a unique database of tumor samples from 399 multiple myeloma (MM) patients, whose functional genomic landscape was assessed by integrating ex vivo drug sensitivity to 138 drugs, clinical variables, cytogenetics, mutational profiles and tra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b5572d3585db54b135e0ec4d00f6401
https://doi.org/10.21203/rs.3.rs-1723993/v1
https://doi.org/10.21203/rs.3.rs-1723993/v1
Publikováno v:
Case Reports in Hematology, Vol 2020 (2020)
Cerebral venous thrombosis (CVT) is a rare condition that can be difficult to diagnose due to its vague and nonspecific symptoms. It is even more unusual to identify CVT in association with malignancy. Given the rarity of this disease, treatment and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02a7d59da799cd9f39320fa1ee3660b1
https://doi.org/10.1155/2020/8849252
https://doi.org/10.1155/2020/8849252
Autor:
Anuhya Kommalapati, Julio C. Chavez, Marco L. Davila, Abu-Sayeef Mirza, Christina A Bachmeier, Frederick L. Locke, Hamza Hashmi, Javier Pinilla-Ibarz, Hien D. Liu, Franco Garcia, Rahul Mhaskar, Constantine Logothetis, Aleksandr Lazaryan, Michael D. Jain, Farhad Khimani, Taiga Nishihori, Bijal D. Shah, Alicia Darwin
Publikováno v:
Blood Adv
Key Points VTE developed in 11% of lymphoma patients after CAR T-cell therapy and was managed safely with anticoagulation. Coagulation abnormalities after CAR T-cell therapy occur but do not commonly lead to bleeding events.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a777bfdfc60afaad8468ad2783e3ac2
https://doi.org/10.1182/bloodadvances.2020002060
https://doi.org/10.1182/bloodadvances.2020002060
Autor:
Michael D Reyes, Nikifor K. Konstantinov, Constantine Logothetis, N. Suzanne Emil, Antonios H. Tzamaloukas
Publikováno v:
Cureus
A man with systemic sclerosis (SS), manifested by characteristic skin lesions, gastro-esophageal reflux disease, and pulmonary fibrosis producing progressive respiratory failure, and a positive antinuclear antibody consistent with reactivity to fibri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45d8fcfe31b50cb25132fecaac021a40
https://doi.org/10.7759/cureus.18064
https://doi.org/10.7759/cureus.18064
Autor:
Gregoire Calon, Virginia O. Volpe, Chetasi Talati, Abida Babu, Constantine Logothetis, Andrew T. Kuykendall, Nicole D. Vincelette, Pukhraz Basra, Jeffrey E. Lancet, David Gajzer, Rami S. Komrokji, Seongseok Yun, Qianxing Mo, David A. Sallman, Najla Al Ali, Kendra Sweet, Eric Padron, Onyee Chan, Ling Zhang
Publikováno v:
Leuk Res
Recent studies demonstrated that MYC epigenetically regulates AML cell survival and differentiation by suppressing IDH1/2-TET2-5hmC signaling and that MYC overexpression is associated with poor survival outcomes in multiple AML patient cohorts. Howev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0684f69917ef85168767121d2f908f0
https://pubmed.ncbi.nlm.nih.gov/34749168
https://pubmed.ncbi.nlm.nih.gov/34749168
Autor:
Nathan Visweshwar, Damian A. Laber, Jennifer Eatrides, Mintallah Haider, Constantine Logothetis, Michael Jaglal, Ankita Patel
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 3418, p 3418 (2021)
Journal of Clinical Medicine
Volume 10
Issue 15
Journal of Clinical Medicine
Volume 10
Issue 15
Caplacizumab prevents platelet adhesion and has been approved for acquired thrombotic thrombocytopenic purpura (aTTP). This study was retrospective, including all patients diagnosed with aTTP and treated with caplacizumab since commercial availabilit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f5398491c6a98296fcb93ec5b8895e9
https://www.mdpi.com/2077-0383/10/15/3418
https://www.mdpi.com/2077-0383/10/15/3418
Autor:
Virginia Olivia Volpe, Nicole D. Vincelette, Onyee Chan, Chetasi Talati, Kendra Sweet, Andrew T. Kuykendall, Constantine Logothetis, Rami S. Komrokji, Gregoire Calon, Nathan P. Horvat, David A. Sallman, Eric Padron, Ling Zhang, Seongseok Yun
Publikováno v:
Blood. 138:2377-2377
Background In AML, IDH1/2 somatic mutations can be frequent in patients at about 20%. Physiologically, IDH1/2 catalyze isocitrate conversion to alpha-ketoglutarate (α-KG). α-KG is an activating co-factor for ten-eleven translocation 2 (TET2), an im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::caf9618d241eebfd5db2cdc56b6d8929
https://doi.org/10.1182/blood-2021-147030
https://doi.org/10.1182/blood-2021-147030
Autor:
Javier Pinilla, Lubomir Sokol, Bijal D. Shah, Sameh Gaballa, Julio C. Chavez, Hayder Saeed, Tony Kurian, Constantine Logothetis, Nathan P. Horvat, Leidy Isenalumhe, Celeste M. Bello
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S405
Context/Objective Marginal zone lymphoma (MZL) is an indolent non-Hodgkin lymphoma (NHL) accounting for 8–12% of NHL. Extra-nodal MZL (EMZL) is the most common subgroup, comprising ~70% of cases. Bendamustine and rituximab (BR) are commonly used as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c59dd2f2015b4707c7ca3835849d58e7
https://doi.org/10.1016/s2152-2650(21)01913-3
https://doi.org/10.1016/s2152-2650(21)01913-3
Autor:
Ling Zhang, Kendra Sweet, Nathan P. Horvat, Virginia O. Volpe, Eric Padron, Nicole D. Vincelette, Chetasi Talati, Seongseok Yun, Gregoire Calon, Onyee Chan, Constantine Logothetis, David A. Sallman, Jeffrey E. Lancet, Rami S. Komrokji, Andrew T. Kuykendall
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S212
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::97ef3ee80cbd835c41e0b896dc21913f
https://doi.org/10.1016/s2152-2650(21)01331-8
https://doi.org/10.1016/s2152-2650(21)01331-8